Search
for
Sort by
Research 301–330 of 1000+
- Allergen desensitization reduces the severity of relapsed alopecia areata in dust‐mite allergic patients
- Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata
- Long-Term Efficacy of Ritlecitinib up to Month 24 From the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata
- Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review
- Alopecia Areata: A Complex Cytokine Driven Disease
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- The Relationship Between ABO And Rh Blood Groups With Alopecia Areata
- Cellular retinol‐binding protein‐1 expression increases with increasing clinical severity of alopecia areata
- 723 - Efficacy of ritlecitinib in patients with alopecia areata by extent of hair loss at baseline: post hoc analysis of the phase 3 long-term ALLEGRO-LT study
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- Systemic Tofacitinib in Alopecia Areata: A Single Center Retrospective Descriptive Cohort Study
- Alopecia Areata
- Serum Epidermal Growth Factor Level and its Relation to Severity of Alopecia Areata
- Evaluation of Intralesional Triamcinolone Acetonide and Platelet‐Rich Plasma Therapy in Patients With Mild Patch‐Type Alopecia Areata
- Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- What is the appropriate indication for baricitinib in patients with alopecia areata? What prior options can be considered?
- What is the appropriate indication for baricitinib in patients with alopecia areata? What prior options can be considered?
- P151 A multicentre real-world evaluation of ritlecitinib in severe alopecia areata: patient-reported outcome measures
- Alopecia Areata With an FFA ‐Like Phenotype: Clinicopathologic Features and Treatment Outcomes in a Prospective Cohort
- AYURVEDIC MANAGEMENT OF ALOPECIA AREATA USING VIDDHAKARMA AS A PARA-SURGICAL PROCEDURE: A CASE STUDY
- Pediatric Clinical Trial Program in Progress: A Phase 3 Study and Long-term Extension Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to <12 years of Age With Severe Alopecia Areata
- Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real‐World Experience
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Holistic assessment of individualized homeopathic therapies in the management of Alopecia areata: A prospective observational study
- Findings from the assessment of real-world disease characteristics and outcomes in alopecia areata in a global non-interventional observational cohort (ADAAGIO) study
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- Combined Low Dose Oral Minoxidil and Immunomodulator Efficacy and Safety in Alopecia Areata: A Systematic Review
- Demographic Features, Clinical Factors and Severity of Disease among Patients with Alopecia Areata